Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Tyme Technologies Inc. (TYME)

1.02   0.015 (1.49%) 11-19 16:00
Open: 1.01 Pre. Close: 1.005
High: 1.04 Low: 1.01
Volume: 173,710 Market Cap: 114M
Tyme Technologies Inc is a clinical-stage pharmaceutical company focused on discovering and developing targeted cancer therapeutics for a broad range of oncology indications. The Company is developing proprietary combination drug product.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.041 - 1.046 1.046 - 1.05
Low: 0.998 - 1.004 1.004 - 1.009
Close: 1.011 - 1.02 1.02 - 1.028

Technical analysis

as of: 2019-11-19 4:30:36 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.56     One year: 1.81
Support: Support1: 0.99    Support2: 0.82
Resistance: Resistance1: 1.34    Resistance2: 1.55
Pivot: 1.19
Moving Average: MA(5): 1.05     MA(20): 1.25
MA(100): 1.27     MA(250): 1.87
MACD: MACD(12,26): -0.09     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 6.91     %D(3): 6.58
RSI: RSI(14): 27.40
52-week: High: 4.64  Low: 0.92  Change(%): -52.6
Average Vol(K): 3-Month: 39291  10-Days: 29064

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TYME has closed above bottom band by 13.7%. Bollinger Bands are 10.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tyme Initiates Pivotal Stage of Pancreatic Cancer Study
Tyme (TYME) initiates the pivotal stage of the TYME-88-Panc study evaluating oral SM-88 (racemetyrosine) for third-line treatment of patients with metastatic pancreatic cancer.

Tyme Technologies to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright on September 9, 2019
Tyme Technologies, Inc. (TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright in New York City on Monday, September 9, 2019. The Company will

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 111.95
Shares Float (M) 53.06
% Held by Insiders 61.02
% Held by Institutions 16.26
Shares Short (K) 7690
Shares Short P. Month (K)

Stock Financials

EPS -0.265
Book Value (p.s.) 0.060
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -84.1
Return on Equity (ttm) -203.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.250
Qtrly Earnings Growth
Operating Cash Flow (M) -18.78
Levered Free Cash Flow (M) -8.43

Stock Valuations

P/E -3.85
P/E Growth Ratio 0.01
P/BV 17.00
P/CF -6.08

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-09-26
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.